The purpose of this is study is to evaluate the long-term safety of DCCR (diazoxide choline) extended-release tablets) in patients with Prader-Willi syndrome.
- Investigator
- Jennifer L Miller
- Ages
- 4 Years - N/A
- Sexes
- All
Clinical trials
-
C614
Update your location to show providers, locations, and services closest to you.
The purpose of this is study is to evaluate the long-term safety of DCCR (diazoxide choline) extended-release tablets) in patients with Prader-Willi syndrome.